Claude’s maker expects to begin trading on Nasdaq as ANT on 19 November. The proposed price range is $70–$78 a share, with a fully diluted valuation of up to about $1.4 trillion.
Here’s what I’m watching beneath the headline:
• Growth: Q3 revenue reached about $17bn, up 47% from Q2.
• Costs: compute consumed roughly $58 of every $100 of Q3 revenue. The GAAP operating result was a loss of about $3 per $100.
• Cash: the nine-month net loss was $104bn, including $94.3bn of non-cash revaluation charges on convertible funding. Operating cash flow over the same nine months was positive $6.6bn.
• Commitments: about $901bn, mainly for compute and infrastructure, stretching to 2045. Some are conditional; about $71bn is expected within 12 months of September.
• Control: the special founder share carries 50.1% of voting power on general shareholder matters. Public shares come with limited influence.
The question is what you pay for the growth—and whether the economics can keep up with the infrastructure bill.
Which would you scrutinise first: valuation, compute costs or governance?
Follow or connect with me to stay updated with the markets.
As of 16 Nov 2026. Pricing and trading dates are expected, subject to regulatory clearance; terms may change. Educational, not financial advice.
Sources: Anthropic S-1/A, 10 Nov 2026; Anthropic IPO FAQs; Kiplinger’s IPO review for the fully diluted valuation.
#Anthropic #Claude #IPO #AI #Investing #FinanceButler
Comments